| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Total revenues | 23,252 | 5,661* | NaN | NaN |
| Cost of products and services | 2,559 | 1,206* | NaN | NaN |
| Research and development | 5,638 | 9,899* | NaN | NaN |
| Selling, general and administrative | 21,049 | 36,299* | NaN | NaN |
| Impairment of goodwill | NaN | 977* | NaN | NaN |
| Impairment of other noncurrent assets | NaN | 0* | NaN | NaN |
| Total operating expenses | 29,246 | 48,380* | NaN | NaN |
| Operating loss | -5,994 | -42,719* | NaN | NaN |
| Change in fair value of warrant liabilities | 0 | 22,591* | NaN | NaN |
| Interest expense | 2,908 | 3,864* | NaN | NaN |
| Interest income | 683 | 461* | NaN | NaN |
| Other income, net | 290 | 22* | NaN | NaN |
| Total other income (expense), net | -1,935 | 19,210* | NaN | NaN |
| Loss before income taxes | -7,929 | -23,509* | NaN | NaN |
| Total revenues | NaN | NaN | 2,922 | 856 |
| Cost of products and services-Service | NaN | NaN | 1,035 | 1,092 |
| Research and development | NaN | NaN | 12,377 | 11,488 |
| Selling, general and administrative | NaN | NaN | 23,991 | 16,133 |
| Impairment of goodwill | NaN | NaN | 0 | 3,907 |
| Impairment of other noncurrent assets | NaN | NaN | 0 | 0 |
| Total operating expenses | NaN | NaN | 37,403 | 32,620 |
| Operating loss | NaN | NaN | -34,481 | -31,764 |
| Change in fair value of warrant liabilities | NaN | NaN | -111,502 | 4,460 |
| Interest expense | NaN | NaN | 902 | 0 |
| Interest income | NaN | NaN | 534 | 696 |
| Other (expense) income, net | NaN | NaN | 7 | -31 |
| Total other expense, net | NaN | NaN | -111,863 | 5,125 |
| Loss before income taxes | NaN | NaN | -146,344 | -26,639 |
| Income tax (expense) benefit | NaN | NaN | 0 | 3 |
| Income tax expense | 0 | -6* | NaN | 3 |
| Net loss | -7,929 | -23,503 | -146,344 | -26,642 |
| Deemed dividend on preferred stock | NaN | 0 | 179,000 | NaN |
| Net gain attributable to common shareholders | NaN | -23,503 | -325,344 | NaN |
| Basic EPS | -0.02 | -0.066 | -1.06 | -0.09 |
| Diluted EPS | -0.02 | -0.066 | -1.06 | -0.09 |
| Basic Average Shares | 354,291,007 | 354,437,379 | 307,170,490 | 296,434,726 |
| Diluted Average Shares | 354,291,007 | 354,437,379 | 307,170,490 | 296,434,726 |
PRECIGEN, INC. (PGEN)
PRECIGEN, INC. (PGEN)